Objective:
To explore how artificial intelligence (AI) can assist in the diagnosis and treatment of dry eye disease (DED).
Approach:
- AI can improve the efficiency of diagnosing ocular surface diseases.
- AI algorithms have shown high accuracy in grading meibomian glands.
- AI can assist in distinguishing between different dry eye subtypes based on staining patterns.
- AI use in dry eye diagnosis is still in early stages.
- Further research is required to understand the full impact of AI.
- Ethical concerns such as data privacy and algorithm bias need to be addressed.
- Artificial intelligence-assisted diagnosis of ocular surface diseases
- The Top Ten Reasons to Use AI in your Dry Eye Practice
- Predicting an unstable tear film through artificial intelligence
- Assessment of corneal fluorescein staining in different dry eye subtypes
- Artificial intelligence in cornea and ocular surface diseases
Key Findings:
Interpretation:
AI has the potential to standardize dry eye assessments and enhance clinical decision-making, but further research is needed to address ethical concerns and improve technology reliability.
Limitations:
Conclusion:
Embracing AI technology in optometry could lead to more accurate diagnoses and treatments for dry eye disease, provided that its limitations are acknowledged and addressed.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
